2.04
+0.03(+1.49%)
Currency In USD
Address
11555 Sorrento Valley Road
Solana Beach, CA 92121
United States of America
Phone
858 224 1000
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
February 14, 2012
| Name | Title | Pay | Year Born |
| Mr. Keith E. Murphy | Executive Chairman & Corporate Secretary | 762,736 | 1972 |
| Mr. Norman Staskey | President, Chief Financial Officer & Principal Financial Officer | 0 | 1970 |
| Dr. Curtis M. Tyree Ph.D. | Senior Vice President of Strategy & Business Development | 0 | N/A |
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.